Podcast: How Accelerated Drug Development Requires Disruption in Market Access and Pricing

We recently sat down with Preeti Patel, MPharm, CEO and Founder of Global Pricing Innovations (GPI), to learn what is driving the growing importance for early stage asset value and price prediction, how GPI is supporting clients through these challenges, and how this solution was developed. GPI is a price and access insights company that uses analytics to provide data-driven, evidence-based support, and helps clients make better investment decisions for drug development and commercialization.

Listen to the conversation.

If you do not see the embedded media player above, access the podcast episode here.

Read the blog.